Genflow Biosciences (OTCQB:GENFF) on Wednesday announced that its second European patent application (Application No. 23821586.7, Publication No. EP4630038), titled “SIRT6 Variant for NASH,” has been published in the European Patent Bulletin.
Publication of the patent application in the European Patent Bulletin follows entry into the European phase under the Patent Cooperation Treaty and represents a key milestone in Genflow’s expanding intellectual property portfolio.
Codelco and SQM have launched the NovaAndino Litio joint venture (JV), which will manage the exploration, extraction, production, and marketing...
Since President Donald Trump's 'Liberation Day' tariffs pushed the U.S. bond market into revolt in April, his administration has carefully...
When markets keep moving up and down and it becomes difficult for investors to predict which investment will perform well...
The National Stock Exchange (NSE) has released its official trading holiday calendar for 2026, offering investors and traders early clarity...
New York: Growing Chinese auto giant BYD stands poised to officially surpass Tesla as the world's biggest electric vehicle company...
Silver retreated sharply after smashing through $80 an ounce for the first time, with traders taking profits from a record-breaking...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.
